Literature DB >> 33665542

Does the SUVmax of FDG-PET/CT Correlate with the ADC Values of DWI in Musculoskeletal Malignancies?

Mesut Ozturk1, Ahmet Veysel Polat2, Fevziye Canbaz Tosun3, Mustafa Bekir Selcuk2.   

Abstract

PURPOSE: To evaluate the correlation of maximum standardized uptake values (SUVmax) of 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) with the apparent diffusion coefficient (ADC) of diffusion weighted imaging (DWI) in musculoskeletal malignancies.
METHODS: Institutional ethics committee approved this retrospective study. Twenty-seven patients (mean age: 44.85 ± 24.07; 17 men and 10 women) with a total of 29 musculoskeletal tumors underwent both FDG-PET/CT and DWI between January 2017 and March 2020. Region-of-interest (ROI)-based maximal standardized uptake values (SUVmax) of the tumors were measured on FDG-PET/CT images. Two radiologists measured lesions' mean and minimum apparent diffusion coefficient (ADCmean and ADCmin) using five distinct ROIs on DWI images. Pearson correlation analysis was used to assess the correlation between SUVmax and ADC values.
RESULTS: There were 18 soft tissue tumors (62.1%) and 11 bone tumors (37.9%) with a mean maximum diameter of 9.4 ± 6.2 cm. The mean SUVmax, ADCmean and ADCmin of the whole lesions were 12.93 ± 9.63, 0.85 ± 0.28 × 10-3mm2/s and 0.61 ± 0.27 × 10-3mm2/s, respectively. SUVmax had a weak correlation with tumor maximum diameter (r = 0.378, p = 0.043), whereas ADCmean and ADCmin had none. There was strong inverse correlation between SUVmax and both ADCmean (r = -0.616, p < 0.001) and ADCmin (r = -0.638, p < 0.001).
CONCLUSION: In musculoskeletal tumors, quantitative markers of FDG uptake and diffusion restriction strongly correlate. Copyright:
© 2021 The Author(s).

Entities:  

Keywords:  PET-CT; bone neoplasm; correlation study; diffusion-weighted MRI; soft tissue sarcoma

Year:  2021        PMID: 33665542      PMCID: PMC7908928          DOI: 10.5334/jbsr.2378

Source DB:  PubMed          Journal:  J Belg Soc Radiol        ISSN: 2514-8281            Impact factor:   1.894


  22 in total

Review 1.  Clinical applications of molecular imaging in sarcoma evaluation.

Authors:  Rodney J Hicks; Guy C Toner; Peter F M Choong
Journal:  Cancer Imaging       Date:  2005-06-21       Impact factor: 3.909

2.  (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.

Authors:  A L Folpe; R H Lyles; J T Sprouse; E U Conrad; J F Eary
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

3.  Impact of ROI Positioning and Lesion Morphology on Apparent Diffusion Coefficient Analysis for the Differentiation Between Benign and Malignant Nonfatty Soft-Tissue Lesions.

Authors:  Chloé Bonarelli; Pedro Augusto Gondim Teixeira; Gabriela Hossu; Jean-Baptiste Meyer; Bailiang Chen; Frédérique Gay; Alain Blum
Journal:  AJR Am J Roentgenol       Date:  2015-07       Impact factor: 3.959

4.  Correlations between intravoxel incoherent motion diffusion-weighted MR imaging parameters and 18F-FDG PET/CT metabolic parameters in patients with vertebral bone metastases: initial experience.

Authors:  Sunghoon Park; Joon-Kee Yoon; Nam-Su Chung; Sang Hyun Kim; Jinwoo Hwang; Hyun Young Lee; Kyu-Sung Kwack
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

5.  Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.

Authors:  Carolyn L Wang; Lawrence R MacDonald; James V Rogers; Aleksandr Aravkin; David R Haseley; J David Beatty
Journal:  AJR Am J Roentgenol       Date:  2011-08       Impact factor: 3.959

6.  Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?

Authors:  S F Hain; M J O'Doherty; J Bingham; C Chinyama; M A Smith
Journal:  Nucl Med Commun       Date:  2003-11       Impact factor: 1.690

7.  Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.

Authors:  Byung Hyun Byun; Chang-Bae Kong; Ilhan Lim; Chang Woon Choi; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Jae-Soo Koh; Soo-Yong Lee; Sang Moo Lim
Journal:  J Nucl Med       Date:  2013-05-13       Impact factor: 10.057

8.  Diffusion-weighted MRI of soft tissue tumours.

Authors:  Hildur Einarsdóttir; Magnus Karlsson; Johan Wejde; Henrik C F Bauer
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

Review 9.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

10.  Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.

Authors:  Rajan Rakheja; Hersh Chandarana; Linda DeMello; Kimberly Jackson; Christian Geppert; David Faul; Christopher Glielmi; Kent P Friedman
Journal:  AJR Am J Roentgenol       Date:  2013-11       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.